Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|KITE-439||KITE 439||KITE-439 consists of autologous T-cells engineered to express a T-cell receptor that recognizes HLA-A*02:01-restricted human papillomavirus type 16 isoform E7 (HPV16 E7) protein, potentially resulting in antitumor activity of cells expressing HPV16 E7 (NCI Drug Dictionary).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|
|NCT03912831||Phase I||Cyclophosphamide + Fludarabine KITE-439||Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers||Recruiting|